Skip to content

Presentations and Abstracts

2017

Vogan A, Schubert C, Merlin T. The impact of treatment timing on the cost-effectiveness of tests. Vignette presentation*. XIV Annual Meeting, Health Technology Assessment international (HTAi), Rome, Italy, 17-21 June 2017.

Merlin T, Hiller JE, Ryan P. Does HTA methodology affect the decision to fund medical tests? Vignette presentation*. XIV Annual meeting, Health Technology Assessment international (HTAi), Rome, Italy, 17-21 June 2017.

Hausner E, Merlin T, O'Rourke B, Chalon P, Mejia A, Waffenschmidt S. Rescuing the HTA database - future options and challenges. Panel presentation*. XIV Annual Meeting, Health Technology Assessment international (HTAi), Rome, Italy, 17-21 June 2017.

2016

Vogan A, Schubert C, Newton S, Merlin T. What are we missing by limiting the outcome of cost effectiveness analyses of diagnostic tests to cost per correct result?. Poster presentation*. XIII Annual Meeting, Health Technology Assessment international (HTAi), Tokyo, 10-14 May 2016.

Parsons J, Newton S, Merlin T. Can lack of clinical utility be used as reason for disinvestment of investigative tests?. Poster presentation*. XIII Annual Meeting, Health Technology Assessment international (HTAi), Tokyo, 10-14 May 2016.

Schubert C, Newton S, Merlin T. Assessing value-for-money for orphan drugs; the mismatch of applied methods, economic theory and available data. Oral presentation*. XIII Annual Meeting, Health Technology Assessment international (HTAi), Tokyo, 10-14 May 2016.

Merlin T, Mujoomdar M, Ahn J, Dedeu I, Baraldes T. Getting a grip on new technologies: INAHTA member agency experiences with m-health, apps, telehealth, and other point-of-care-technologies. Panel presentation*. XIII Annual Meeting, Health Technology Assessment international (HTAi), Tokyo, Japan, 10-14 May 2016.

Merlin T, Panteli D, Espin J, Lepanto L, Ramsay C. HTA in academic curricula: demand, experience, ways forward and potential for collaboration. Workshop. XIII Annual Meeting, Health Technology Assessment international (HTAi), Tokyo, Japan, 10-14 May 2016.

  • See More

    2015

    Merlin T. HTA for companion diagnostics: different models and best practices to make it possible. Invited presentation*. European Diagnostics Manufactuers Association (EDMA), Brussels, 11 June 2015.

    Lopes do Carmo E, Street J, Carter D, Merlin T. Stakeholders views on Australian public and patient involvement in HTA. Oral presentation*.12th Annual Meeting, Health Technology Assessment international (HTAi), Oslo, 13-17 June 2015.

    Merlin T (Panel coordinator and speaker), Mujoomdar M, Kisser A, Wurcel V. Living in testing times: translating evidence on medical tests and companion diagnostics into reimbursement decisions. Panel presentation*.12th Annual Meeting, Health Technology Assessment international (HTAi), Oslo, 13-17 June 2015.

    Vogan A, Mitchell A, Tamblyn D & Merlin T. Managed entry schemes: enabling access to oncology drugs under uncertainty. Poster presentation*.12th Annual Meeting, Health Technology Assessment international (HTAi), Oslo, 13-17 June 2015.

    Kessels S, Morona J, Newton S & Merlin T. The impact of an imperfect reference standard. Poster presentation*.12th Annual Meeting, Health Technology Assessment international (HTAi), Oslo, 13-17 June 2015.

    Pridham L, Liufu Z, Newton S & Merlin T. International comparison of subsidisation of drugs for rare diseases and the definitions for rare/ultra-rare disease. Poster presentation*.12th Annual Meeting, Health Technology Assessment international (HTAi), Oslo, 13-17 June 2015.

    Morona J, Newton S & Merlin T. Meta-analysis of two tests via a common reference standard for detection of Tuberculosis infections. Poster presentation*.12th Annual Meeting, Health Technology Assessment international (HTAi), Oslo, 13-17 June 2015.

    2014

    Vogan A, Schubert C, Parsons J, Morona J & Merlin T. The impact of an imperfect diagnostic reference standard on the cost-effectiveness of HbA1c testing in the diagnosis of Type II diabetes. Oral presentation*.11th Annual Meeting, Health Technology Assessment international (HTAi), Washington DC, 16-18 June 2014.

    Kessels S, Schubert C, Newton S & Merlin T. Assessment of catheter-free (wireless)ambulatory oesophageal pH monitoring for Gastro-esophageal Reflux Disease (GORD). Poster presentation*. 11th Annual Meeting, Health Technology Assessment international (HTAi), Washington DC, 16-18 June 2014.

    Newton S, Milverton J & Kessels, S. Technology to assist with guideline development: software for systematic reviews. Oral presentation*. 11th G-I-N Conference, Melbourne, 20-23 August 2014.

    Milverton J, Ellery B, Newton S, Kessels S, Gum D & Merlin T. CT colonography for those at high risk or symptomatic for colorectal cancer. Poster/Oral presentation*. 11th G-I-N Conference, Melbourne, 20-23 August 2014.

    Vogan A, Schubert C, Parsons J, Morona J & Merlin T. Assessing the cost-effectiveness of HbA1c testing in the diagnosis of Type II diabetes and the impact of an imperfect diagnostic reference standard. Poster presentation*. 36th Annual Meeting of the Society for Medical Decision Making, Miami, 22 October 2014.

    2013

    Newton S, Wang S, Schubert, Merlin T. One small step for an individual, one giant leap for their family: considerations required for assessing the cost effectiveness of genetic tests. Oral presentation*. 10th HTAi 2013, Seoul, 15-19 June 2013.

    Newton S, Fitzgerald P, Merlin T. Mutation testing of the RET gene got MEN2. Poster presentation*. 10th HTAi 2013, Seoul, 15-19 June 2013.

    Morona J, Newton S, Ellery B, Merlin T. Genetic testing for VHL disease: limited benefit to the individual, but reduced surveillance for family members. Poster presentation*. 10th HTAi 2013, Seoul, 15-19 June 2013.

    Merlin T, Ellery B, Juneja V, Tamblyn D. What's in a name? - mapping the different HTA products of INAHTA members. Oral presentation*. 10th HTAi 2013, Seoul, 15-19 June 2013.

    Morona J, Buckley E, Reddin E, and Merlin T. The use of growth factors to promote healing of diabetic foot ulcers: A Systematic Review.  Poster presentation*.2013 Australasian Cochrane Symposium, Melbourne, 20-21 November 2013.

    2012

    Merlin T. Impact of Health Technology Assessment – AHTA’s perspective. International Network of Agencies for Health Technology Assessment Annual Meeting. Bilbao, Spain. June 28, 2012.

    Merlin T, Farah C, Schubert C, Mitchell A, Hiller JE, Ryan P. How to assess personalised medicines for reimbursement decisions? Developing a framework for Australia. Oral presentation*. IX Annual Meeting HTAi 2012, Bilbao, 25-27 June 2012.

    Merlin T, Street J. Keeping an eye on the problem: developing a disinvestment methodology to review Australian medical services – ‘ophthalmology’ as a test case. Oral presentation*. IX Annual Meeting HTAi 2012, Bilbao, 25-27 June 2012.

    2011

    Merlin T. Challenges for independent evaluation: MSAC assessments – past, present and future. ARCS Scientific Congress, National Convention Centre, Canberra. August 2, 2011.

    Merlin T. Feasibility of the linked evidence approach when assessing diagnostic tests for public funding. Screening and Test Evaluation Program (STEP) Seminar, University of Sydney, Sydney. March 16, 2011.

    Hennessy S, Street J, Scrimgeour S & Merlin T. A rapid review of patient perspectives on cataract surgery collected using peer-reviewed literature and personal blogs: a comparison with patient interviews. Oral presentation*.HSRAANZ Health services and policy research conference, Adelaide, 5-7 December, 2011.

    2010

    Merlin T, Lehman S. The benefits and flaws of the Linked Evidence Approach (LEA) to assess diagnostic and screening tests. Poster presentation*. 7th Annual Meeting, Health Technology Assessment international (HTAi), Dublin, 6-9 June, 2010.

    Merlin T, Liufu Z & Wang S. Unattended sleep studies in the diagnosis of obstructive sleep apnoea. Poster presentation*. 7th Annual Meeting, Health Technology Assessment international (HTAi), Dublin, 6-9 June, 2010.

    Buckley E, Wang S, Merlin T & Hiller JE. Use of disease prevalence when estimating the positive predictive value of a test can mislead: the spectrum effect. Poster presentation*. 7th Annual Meeting, Health Technology Assessment international (HTAi), Dublin, 6-9 June, 2010.

    Buckley E, Merlin T, Mundy L & Hiller JE. Molecular testing for myeloproliferative disease: The conundrum of an imperfect reference standard. Poster presentation*. 7th Annual Meeting, Health Technology Assessment international (HTAi), Dublin, 6-9 June, 2010.

    Penner A, Mundy L & Hiller JE. M5-03 Horizon scanning for new and emerging health technologies in Australia: Does it address the Australian national health priority areas. 7th Annual Meeting, Health Technology Assessment international (HTAi), Dublin, 6-9 June, 2010. Page 170.

    Mundy L, Watt, A & Hiller JE. Direct-to-consumer marketing in Australia: Health Technology Assessment missing in action. Oral presentation*. 40th Annual Conference, Public Health Association of Australia (PHAA), Adelaide. 27-29 September, 2010.

    Mundy L, Hiller JE. HT1. Early alert systems for new pharmaceuticals - do they have an impact on pharmaceutical reimbursement decisions: a cross - national Comparison. 4th Asia-Pacific Conference, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Phuket, 2-7 September, 2010. Page 62.

    2009

    Mundy L, Merlin T & Hiller JE. Early alert systems for new pharmaceuticals - do they have an impact on pharmaceutical public reimbursement decisions?: A cross-national comparison Globalisation and Health Technology Assessment Poster Presentation*. 6th Annual Meeting, Health Technology Assessment international (HTAi), Singapore, 21-24 June 2009.

    Elshaug AG. Reallocating Resources in Health Care Systems: The Role of HTA Units in Identifying Existing Technologies of Low Added Value. Presenter and Chair of panel session*. 6th Annual Meeting, Health Technology Assessment international (HTAi), Singapore, 21-24 June 2009.

    Newton S, Street J, Merlin T & Hiller JE. Is MRI effective for staging newly diagnosed rectal carcinoma? That depends on whether it changes management. Oral presentation*. 6th Annual Meeting, Health Technology Assessment international (HTAi), Singapore, 21-24 June 2009.

    Ju H, Newton S, Merlin T & Hiller JE. Quality assessment of clinical practice guidelines (CPGs): Is ADAPTE adaptable? Poster presentation*. 6th Annual meeting, Health Technology Assessment international (HTAi), Singapore, 21-24 June 2009.

    Wang S, Gum D, Merlin T & Hiller JE. Predictors of vaccination uptake and course completion: A systematic review. Poster presentation. 6th Annual Meeting, Health Technology Assessment international (HTAi), Singapore, 21-24 June 2009.

    Elshaug AG. Guideline development for Disinvestment. Osteba Multi-Sector Disinvestment Workshop, Bilbao, 12-14 May 2009.

    Elshaug AG. Does Surgery Have a role in the Treatment of OSA? A Health Policy Perspective. 3rd International Symposium on Surgery, Sleep and Breathing. International Surgical Sleep Society. Amsterdam, 8-9 May 2009.

    Elshaug AG. Assessment of Clinical Utility and Implementation of Change. Annual Scientific Education Symposium, Australasian Association of Clinical Biochemists (AACB). Adelaide, 1 May 2009.

    2008

    Kreisz FP, Merlin T, Hiller JE & Gericke C. The cost-utility of 64-slice computed tomography coronary angiography in the detection of significant obstructive coronary artery disease. Poster presentation*. 7th European Conference on Health Economics, Rome, 23-26 July 2008.

    Elshaug AG. International perspectives on disinvestment from ineffective health care practices. Oral presentation*. 5th Annual Meeting, Health Technology Assessment international (HTAi). Montreal, July 6-9 2008.

    Elshaug AG. Disinvestment from existing ineffective health care practices. Introducing innovation in Healthcare Systems. EuroScan and Osteba Conference. Bilbao, April 2-4 2008.

    Kreisz FP, Merlin T, Atherton J, Hiller J, Gericke C. The pre-test risk stratified cost-effectiveness of 64-slice computed tomography coronary angiography in the detection of significant obstructive coronary artery disease. Oral presentation*. 5th Annual Meeting Health Technology Assessment international (HTAi), Montreal, 6-9 July 2008.

    Merlin TL, Moss J, Hiller JE. Location, location, location - the impact of health care setting of technology use on both HTA results and funding policy. Poster presentation*. 5th Annual Meeting, Health Technology Assessment international (HTAi), Montreal, 6-9 July 2008.

    Merlin TL, Newton S, Wang S, Hiller J. Technology assessment in the context of workforce shortages and changing supply: Digital mammography. Oral presentation*. 5th Annual Meeting, Health Technology Assessment international (HTAi), Montreal, 6-9 July, 2008.

    Wang S, Merlin T, Kreisz F, Craft P, Hiller JE, Cost-effectiveness of digital mammography compared with film-screen mammography in Australia. Poster presentation*. Population Health Congress, Brisbane, 6-9 July 2008.

    2007

    Elshaug AG, Hiller JE & Moss JR. Exploring Policymakers' Perspective on Disinvestment from Ineffective Health Care Practices. 5th Health Services Research Association of Australia and New Zealalnd (HSRAANZ) conference, Auckland, 2-5 December  2007.

    Elshaug AG, Hiller JE & Moss JR. Disinvestment from Ineffective Health care Practices: An Exploration of Policymakers' Perspectives. The Menzies centre for health Policy, Emerging Health Policy Research Conference. Canberra, 12 October 2007. 
     
    Ivan M, Merlin T, Hiller JE, Newton S, Sullivan T, Buckley L & Hedayati H. Multi-slice computed tomography or conventional coronary angiography - how a systematic review of safety and effectiveness can inform decision-making. Oral Presentation*. State Population Health conference, Adelaide, 20 October 2007.

    Hiller JE, Moyes L, Mundy L & Merlin T. Horizon scanning for public health interventions. 4th Annual Meeting Health Technology Assessment international (HTAi), Barcelona, 17 -20 June 2007. Book of Abstracts pp. 93.

    Banham D, Merlin T, Woollacott T. Evaluating overweight/obesity health promotion activities on multiple criteria (of effectiveness, efficiency and equity). Oral presentation*. Australian Health Promotion Association's 17th National Conference, Adelaide, 1-4 May 2007.

    2006

    Elshaug AG, Hiller JE, Southcott AM & Moss JR. An Audit of Surgical Intervention for Obstructive Sleep Apnoea: Questions of Efficacy and Improved Health Outcomes. Oral Presentation*. 3rd Annual Meeting, Health Technology Assessment international (HTAi), Adelaide. 3-5 July 2006.

    Elshaug AG, Hiller JE, Southcott AM & Moss JR. When clinical practices vary, best practice is one of multiple variations: a practical analysis of the know-do-gap. Canadian Association for Health Services and Policy Research (CAHSPR) annual conference, Vancouver, 17-19 September 2006. p.53.

    Elshaug AG, Hiller JE, Southcott AM & Moss JR. When clinical practices vary, best practice is one of multiple variations: need for a formal mechanism to monitor effectiveness. The 6th International Conference on Priorities in health Care, Toronto, 20-22 September 2006.

    Elshaug AG, Moss JR & Hiller JE. Inverse care law: a micro level example in Australia. International Society for Equity in Health (ISEqH) 4th Biennial International Conference, Adelaide, 11-13 September 2006.

    McCaffrey N, Merlin T & Hiller J. Lack of clinical rationale provided for non-inferiority margins. Poster presentation*. 3rd Annual meeting, Health Technology Assessment international (HTAi), Adelaide, 3-5 July 2006.
     
    Merlin T, Newton S, Thomson K & Hiller JE. Brittle bones and painful backs: a systematic review of the safety and effectiveness of vertebroplasty. Poster presentation*. 3rd Annual meeting, Health Technology Assessment international (HTAi), Adelaide, 3-5 July 2006.

    Merlin T, Brooks A, Lord S & Hiller JE. How to assess the effectiveness of a triage test in the context of direct versus linked evidence? Poster Presentation*. 3rd Annual meeting, Health Technology Assessment international (HTAi), Adelaide, 3-5 July 2006.

    Mundy L, Merlin T, Sullivan T & Hiller JE. Determining the fate of a health technology: why some technologies don't get off first base. Poster presentation*. 3rd Annual meeting, Health Technology Assessment international (HTAi), Adelaide, 3-5 July 2006.

    Newton S, Merlin T, Forbes D, Phelps A, Creamer M & Hiller J. Challenges in updating evidence-based clinical practice guidelines. Oral presentation*. 3rd Annual meeting, Health Technology Assessment international (HTAi), Adelaide, 3-5 July 2006.

    Newton S, Merlin T, Hedayati H, Thomson K & Hiller J. Kyphoplasty for treating vertebral compression fractures with kyphosis. Poster presentation*. 3rd Annual meeting, Health Technology Assessment international (HTAi), Adelaide, 3-5 July 2006.

    Sullivan T, Merlin T, Mundy L & Hiller JE. Horizon scanning activity as a marker for changing patterns in medical research. Oral presentation*. 3rd Annual meeting, Health Technology Assessment international (HTAi), Adelaide, 3-5 July 2006.

    2005

    Elshaug AG, Hiller JE & Moss JR. When clinical practices vary, best practice is only one of multiple variations: need for a formal mechanism to monitor effectiveness. 4th Health Services and Policy Research Conference (Health Services Research Association of Australia and New Zealand). Canberra, 13-16 November 2005.

    Merlin T, Middleton P, Salisbury J & Weston A. Ways to ensure evidence-based clinical practice guidelines are of high quality. Discussion workshop*. XII Cochrane Colloquium, Melbourne, 22-26 October 2005. W52, p196

    Merlin T, Weston A, Tooher R & (NHMRC "Levels" Working Party). Re-assessing and revising "levels of evidence" in the critical appraisal process. Oral presentation*. XIII Cochrane Colloquium, Melbourne,22-26 October 2005. O32, p. 9.49.

    Merlin T, Hodgkinson B, Moss J & Hiller JE. Economic analysis within a health technology assessment: practical issues. Italian Journal of Public Health (Supplement 1), Summer 2005, Year 3, 2(2): 262. Poster presentation*. Bringing HTA into practice, 2nd Annual Meeting, Rome, 20-22 2005.

    Mundy L, Merlin T, Parrella A & Hiller JE. The Australian horizon scanning network. Italian Journal of Public Health (Supplement 1), Summer 2005, Year 3 2(2): 163. Oral presentation*. Bringing HTA into practice, 2nd Annual Meeting, Rome, 20-22 June 2005.

    Merlin T, Weston A & Tooher R. Revising a national standard: redevelopment of the Australian NHMRC evidence hierarchy. Italian Journal of Public Health (Supplement 1), Summer 2005, Year 3, 2(2): 156 Oral presentation*. Bringing HTA into practice, 2nd Annual Meeting, Rome, 20-22 June 2005.

    2004

    Hodgkinson B, Moss J, Merlin T & Hiller JE. Economic analysis within a health technology assessment: practical issues. Oral presentation*. Regional Conference on Cost Effective Healthcare, Singapore. 22-23 October 2004.

    Merlin TL, Hiller JE. Are institutionalised approaches to pain assessment and management effective? A systematic review. Poster presentation*. 1st Annual Meeting, Health Technology Assessment international (HTAi), Krakow, 20 May - 2 June 2004.

    Merlin TL, Mundy L & Hiller JE. Caught between a rock and a hard place: indirect comparisons and the trade-off between information and methodological rigour. Poster presentation*. 1st Annual Meeting, Health Technology Assessment international (HTAi), Krakow, 30 May - 2 June 2004.

    Merlin TL, Hiller JE, Babidge W, McConnell A & Kearney B. The development of the Australia and New Zealand Horizon Scanning Network and its impact onpolicy. Oral presentation*. 1st Annual Meeting, Health Technology Assessment international (HTAi), Krakow, 30 May - 2 June 2004.

    2003

    Merlin TL. Indirect comparisons (Workshop 2 - Methods: Therapy). Oral presentation*. MSAC Evaluator's Meeting. Melbourne, 20 November 2003.

    Merlin TL, Hiller JE. Are institutionalised approaches to pain assessment and management effective? A systematic review. Poster presentation*. Health Services Research Association of Australia and New Zealand Conference, Melbourne, 16-19 November 2003.

    Hodgkinson B, Moss J, Merlin TL & Hiller JE. When the comparator is 'usual care': an example from osteoarthritis of the knee. Oral presentation*. 19th Annual Meeting, International Society of Technology Assessment in Health Care, Canmore, 22-25 June 2003.

    Merlin TL, Mundy L, Dekker GA & Hiller JE. Antenatal screening for heritable thrombophilia: Is public funding merited? Poster presentation*. 19th Annual Meeting, International Society of Technology Assessment in Health Care, Canmore, 22-25 June 2003.

    Merlin TL, Mundy L, Dekker G & Hiller JE. Antenatal screening for heritable thrombophilia: what is the evidence? Oral presentation*. Perinatal Society of Australia and New Zealand Congress, Hobart, March 2003.

    2002

    Hiller JE, Merlin T, Mundy L & Hodgkinson B. What is MSAC and what do we do for them? Oral presentation*. Department of Public Health, University of Adelaide. September 2002.

    Merlin T. Methodological considerations in a surgical systematic review. Oral presentation*. Cochrane Non-Randomised Studies Methods Group meeting. Oxford, July 2002.

    2001

    Merlin T. What access method is the safest and most effective at establishing pneumoperitoneum in laparoscopic surgery? A systematic review. Oral presentation. Department of Public Health, University of Adelaide. October 2001.

School of Public Health
The University of Adelaide
Address

Mail Drop 545 or 511
Level 9, Adelaide Health & Medical Sciences Building
SA  5005  AUSTRALIA

Contact

T: +61 8 8313 4617
T: +61 8 8313 3576
ahta@adelaide.edu.au

AHTA Logo